Pelvic Inflammatory Disease (PID) Treatment Global Market Report 2025

Description

Pelvic inflammatory disease (PID) treatment involves the medical management of infections affecting the female reproductive organs, typically caused by sexually transmitted bacteria such as Chlamydia trachomatis and Neisseria gonorrhoeae. The goal of treatment is to eliminate the infection, alleviate symptoms, and prevent complications such as infertility, chronic pelvic pain, and ectopic pregnancy.

The main types of PID treatment include antibiotic therapy, surgery, pain management, and hormonal therapy. Antibiotic therapy involves using antibiotics to treat bacterial infections by killing or inhibiting the growth of bacteria. It can be administered orally, intravenously, or intramuscularly, and PID treatment is available in hospitals, clinics, and home care settings.

The pelvic inflammatory disease (PID) treatment market research report is one of a series of new reports from The Business Research Company that provides pelvic inflammatory disease (PID) treatment market statistics, including the pelvic inflammatory disease (PID) treatment industry global market size, regional shares, competitors with the pelvic inflammatory disease (PID) treatment market share, detailed pelvic inflammatory disease (PID) treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the pelvic inflammatory disease (PID) treatment industry. This pelvic inflammatory disease (PID) treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pelvic inflammatory disease (PID) treatment market size has grown strongly in recent years. It will grow from $4.49 billion in 2024 to $4.75 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the growing adoption of telemedicine, the rising incidence of sexually transmitted infections (STIs), increasing awareness of pelvic inflammatory disease (PID), and higher healthcare expenditure.

The pelvic inflammatory disease (PID) treatment market size is expected to see strong growth in the next few years. It will grow to $5.88 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth during the forecast period can be attributed to the increasing prevalence of sexually transmitted infections (STIs), rising awareness regarding women's reproductive health, growing awareness of pelvic inflammatory disease (PID), increasing reliance on telehealth services, and a rising incidence of STIs. Key trends expected during this period include innovative PID treatment products, advancements in diagnostic technologies, innovations in personalized treatment, advanced imaging techniques, and other technological advancements.

The rising prevalence of sexually transmitted infections (STIs) is expected to drive the growth of the pelvic inflammatory disease (PID) treatment market. STIs are infections caused by bacteria, viruses, or parasites that are primarily spread through sexual contact, including vaginal, anal, or oral sex. The increasing prevalence of STIs is attributed to factors such as risky sexual behaviors, unprotected sex, lack of awareness, and delayed testing and treatment. PID treatment is crucial for managing STIs, as it involves the use of antibiotics to eliminate the bacteria causing the infection, preventing complications such as chronic pelvic pain and infertility, and reducing the risk of recurrent infections. For example, in October 2024, a report from the UK Health Security Agency (UKHSA) revealed that in 2023, England recorded 6,008 new HIV diagnoses, marking a 51% increase compared to 3,975 in 2022. Therefore, the growing prevalence of STIs is driving the expansion of the PID treatment market.

Companies operating in the pelvic inflammatory disease (PID) treatment market are focusing on developing innovative formulations, such as probiotic supplements, to enhance treatment efficacy, restore vaginal microbiota balance, and reduce the recurrence of infections in PID patients. Probiotic supplements contain beneficial live bacteria or yeasts that help maintain or restore a healthy balance of the gut and vaginal microbiota. For example, in November 2024, Lee Health Domain, an India-based pharmaceutical company, launched V-Ferin, a probiotic supplement aimed at supporting vaginal health. Formulated with Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, V-Ferin seeks to restore the natural microbiome and prevent common vaginal infections such as bacterial vaginosis and yeast infections. With approximately 25-30% of women affected by these conditions, which can lead to PID if left untreated, V-Ferin offers an innovative solution to improve health and prevent complications.

In February 2022, Mankind Pharma Limited, an India-based pharmaceutical company, acquired Panacea Biotec Limited (PBL) for $212.88 million. This acquisition strengthens Mankind Pharma's position in the chronic and transplant business by integrating well-researched formulations and leveraging advanced technology and niche expertise, while retaining Panacea Biotec's sales and marketing team to ensure seamless business operations and market expansion. Panacea Biotec Limited is an India-based biotechnology company that develops, manufactures, and commercializes pharmaceuticals, vaccines, and biosimilars for various diseases, including pelvic inflammatory disease (PID).

Major players in the pelvic inflammatory disease (PID) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., and Amagen India Life Sciences.

North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pelvic inflammatory disease (PID) treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pelvic inflammatory disease (PID) treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pelvic inflammatory disease (PID) treatment market consists of revenues earned by entities by providing services such as medication therapy, pain management, and hospital and clinic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pelvic inflammatory disease (PID) treatment market includes sales of antibiotics, pain relievers, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the specified geography within the market, irrespective of where they are produced. They do not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pelvic Inflammatory Disease (PID) Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pelvic inflammatory disease (pid) treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pelvic inflammatory disease (pid) treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pelvic inflammatory disease (pid) treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Type: Antibiotic Therapy; Surgery; Pain Management; Hormonal Therapy
2) By Route Of Administration: Oral; Intravenous; Intramuscular
3) By End User: Hospitals; Clinics; Homecare
Subsegments:
1) By Antibiotic Therapy: Broad-spectrum Antibiotics; Combination Antibiotic Therapy; Oral Antibiotics; Intravenous Antibiotics
2) By Surgery: Laparoscopy; Hysterectomy; Tubal Surgery
3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs); Opioid Analgesics; Acetaminophen; Localized Pain Management
4) By Hormonal Therapy: Birth Control Pills; Hormonal Intrauterine Device (IUD); Progesterone Therapy
Companies Mentioned:Pfizer Inc.; Bayer AG; Eli Lilly and Company; Otsuka Pharmaceutical Co. Ltd.; Astellas Pharma Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34117

1. Executive Summary

2. Pelvic Inflammatory Disease (PID) Treatment Market Characteristics

3. Pelvic Inflammatory Disease (PID) Treatment Market Trends And Strategies

4. Pelvic Inflammatory Disease (PID) Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pelvic Inflammatory Disease (PID) Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Pelvic Inflammatory Disease (PID) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pelvic Inflammatory Disease (PID) Treatment Market Growth Rate Analysis
5.4. Global Pelvic Inflammatory Disease (PID) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pelvic Inflammatory Disease (PID) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pelvic Inflammatory Disease (PID) Treatment Total Addressable Market (TAM)

6. Pelvic Inflammatory Disease (PID) Treatment Market Segmentation

6.1. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotic Therapy
Surgery
Pain Management
Hormonal Therapy
6.2. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Intramuscular
6.3. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare
6.4. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Broad-spectrum Antibiotics
Combination Antibiotic Therapy
Oral Antibiotics
Intravenous Antibiotics
6.5. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laparoscopy
Hysterectomy
Tubal Surgery
6.6. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Pain Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Opioid Analgesics
Acetaminophen
Localized Pain Management
6.7. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Birth Control Pills
Hormonal Intrauterine Device (IUD)
Progesterone Therapy

7. Pelvic Inflammatory Disease (PID) Treatment Market Regional And Country Analysis

7.1. Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market

8.1. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pelvic Inflammatory Disease (PID) Treatment Market

9.1. China Pelvic Inflammatory Disease (PID) Treatment Market Overview
9.2. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pelvic Inflammatory Disease (PID) Treatment Market

10.1. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pelvic Inflammatory Disease (PID) Treatment Market

11.1. Japan Pelvic Inflammatory Disease (PID) Treatment Market Overview
11.2. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pelvic Inflammatory Disease (PID) Treatment Market

12.1. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market

13.1. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pelvic Inflammatory Disease (PID) Treatment Market

14.1. South Korea Pelvic Inflammatory Disease (PID) Treatment Market Overview
14.2. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market

15.1. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market Overview
15.2. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pelvic Inflammatory Disease (PID) Treatment Market

16.1. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pelvic Inflammatory Disease (PID) Treatment Market

17.1. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pelvic Inflammatory Disease (PID) Treatment Market

18.1. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pelvic Inflammatory Disease (PID) Treatment Market

19.1. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pelvic Inflammatory Disease (PID) Treatment Market

20.1. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market

21.1. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market Overview
21.2. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pelvic Inflammatory Disease (PID) Treatment Market

22.1. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pelvic Inflammatory Disease (PID) Treatment Market

23.1. North America Pelvic Inflammatory Disease (PID) Treatment Market Overview
23.2. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pelvic Inflammatory Disease (PID) Treatment Market

24.1. USA Pelvic Inflammatory Disease (PID) Treatment Market Overview
24.2. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pelvic Inflammatory Disease (PID) Treatment Market

25.1. Canada Pelvic Inflammatory Disease (PID) Treatment Market Overview
25.2. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pelvic Inflammatory Disease (PID) Treatment Market

26.1. South America Pelvic Inflammatory Disease (PID) Treatment Market Overview
26.2. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pelvic Inflammatory Disease (PID) Treatment Market

27.1. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pelvic Inflammatory Disease (PID) Treatment Market

28.1. Middle East Pelvic Inflammatory Disease (PID) Treatment Market Overview
28.2. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pelvic Inflammatory Disease (PID) Treatment Market

29.1. Africa Pelvic Inflammatory Disease (PID) Treatment Market Overview
29.2. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pelvic Inflammatory Disease (PID) Treatment Market Competitive Landscape And Company Profiles

30.1. Pelvic Inflammatory Disease (PID) Treatment Market Competitive Landscape
30.2. Pelvic Inflammatory Disease (PID) Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pelvic Inflammatory Disease (PID) Treatment Market Other Major And Innovative Companies

31.1. Daiichi Sankyo Company Limited
31.2. Hetero Drugs Ltd.
31.3. Sun Pharmaceutical Industries Ltd.
31.4. Takeda Pharmaceutical Company Limited
31.5. Dr. Reddy's Laboratories Ltd.
31.6. Cipla Limited
31.7. Hikma Pharmaceuticals PLC
31.8. Lupin Pharmaceuticals Inc.
31.9. Torrent Pharmaceuticals Ltd.
31.10. Mankind Pharma Ltd.
31.11. Mayne Pharma Group Limited
31.12. Saphnix Lifesciences
31.13. Aristo Pharmaceuticals Pvt. Ltd.
31.14. Zydus Cadila Healthcare Ltd.
31.15. Amagen India Life Sciences

32. Global Pelvic Inflammatory Disease (PID) Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pelvic Inflammatory Disease (PID) Treatment Market

34. Recent Developments In The Pelvic Inflammatory Disease (PID) Treatment Market

35. Pelvic Inflammatory Disease (PID) Treatment Market High Potential Countries, Segments and Strategies

35.1 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer